 Levels trial
was the ﬁrst study to demonstrate the beneﬁts of statin
therapy in preventing recurrent stroke. Among 4731 patients who had experienced a stroke or TIA within 1 to
6 months of randomization to atorvastatin 80 mg/day or
placebo, there was a 33% decrease in the incidence of fatal
or nonfatal stroke and a 42% decrease in the overall incidence of cardiovascular events.8